Market Cap 3.61B 961M 844M 785M 720M 1.35B 92.53B 1.37B 9.32B 3.64B 45.49B 3.53B 157B P/E 2026 *
16.2x
P/E 2027 * 14.5x
Enterprise Value 4.56B 1.21B 1.07B 991M 910M 1.71B 117B 1.74B 11.77B 4.6B 57.46B 4.46B 199B EV / Sales 2026 *
2.8x
EV / Sales 2027 * 2.32x
Free-Float
78.97%
Yield 2026 *
1.97%
Yield 2027 * 3.3%
1 day-1.50%
1 week+2.79%
Current month+6.94%
1 month+4.57%
3 months-4.85%
6 months+8.55%
Current year+15.96%
1 week 28.6
Extreme 28.6
30.8
1 month 28.1
Extreme 28.1
30.8
Current year 24.96
Extreme 24.96
33.12
1 year 24
Extreme 24
33.12
3 years 20.94
Extreme 20.94
42.85
5 years 20.94
Extreme 20.94
61.4
10 years 20.94
Extreme 20.94
61.4
Manager TitleAgeSince
Chief Executive Officer 58 05/01/2021
Chief Executive Officer - 07/04/2025
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member - 03/04/2016
Director/Board Member - 03/04/2019
Director/Board Member - 03/04/2019
Change 5-day change 1-year change 3-year change Capi.($)
-1.50%+2.79%+23.60%-22.51% 961M
+0.85%+1.22%+48.17%+159.83% 1,057B
+1.52%+4.03%+55.24%+53.86% 624B
-0.39%+1.73%+35.66%+80.81% 454B
+1.60%+7.09%+35.90%+29.32% 341B
-0.60%+2.95%+36.28%+39.04% 297B
-0.14%+0.60%+16.17%+17.53% 262B
+0.09%-2.82%-28.29%-41.71% 215B
-0.54%+2.82%+22.06%+59.98% 201B
-1.23%-3.22%+14.81%+67.34% 162B
Average +0.20%+0.98%+25.96%+44.35% 361.49B
Weighted average by Cap. +0.59%+1.57%+35.86%+77.31%

Financials

2026 *2027 *
Net sales 1.62B 433M 380M 354M 324M 610M 41.69B 619M 4.2B 1.64B 20.49B 1.59B 70.86B 1.92B 513M 450M 419M 384M 722M 49.37B 733M 4.97B 1.94B 24.27B 1.88B 83.93B
Net income 224M 59.8M 52.52M 48.85M 44.82M 84.22M 5.76B 85.52M 580M 227M 2.83B 220M 9.79B 253M 67.38M 59.18M 55.04M 50.5M 94.89M 6.49B 96.35M 654M 255M 3.19B 247M 11.03B
Net Debt 950M 253M 222M 207M 190M 356M 24.36B 362M 2.45B 958M 11.97B 929M 41.4B 863M 230M 202M 188M 172M 324M 22.13B 329M 2.23B 871M 10.88B 844M 37.63B
Logo Saudi Pharmaceutical Industries and Medical Appliances Corporation
Saudi Pharmaceutical Industries and Medical Appliances Corp SPIMACO ADDWAEIH SJSC is a Saudi Arabia based pharmaceutical company. The Company is primarily engaged in manufacturing of pharmaceutical products, medicines for human use and wholesale and retail of medicines and related products, development and marketing of medical and pharmaceutical products, research and development in medical science activities, operating and maintaining the healthcare facilities and any investments in related industries. The Company is organized into four segments which include Pharmaceutical Manufacturing, Trading and Distribution Services, Healthcare Services and Discontinued Operation. Products of the Company include tablets, capsules, syrups and suspensions, injections, creams, ointments and gels, suppositories, mouthwash and antiseptic products. The Subsidiaries of the Company include ARACOM Medical Company, Dammam Pharmaceutical Company, SPIMACO Misr Company for Distribution and others.
Employees
-
Date Price Change Volume
23/07/26 SAR 30.22 -1.50% 315,942
22/07/26 SAR 30.68 +4.28% 865,006
21/07/26 SAR 29.42 +0.20% 171,383
20/07/26 SAR 29.36 +0.69% 264,102
19/07/26 SAR 29.16 -0.82% 182,138
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
3
Last Close Price
30.22SAR
Average target price
31.86SAR
Spread / Average Target
+5.44%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 2070 Stock